Transcept Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the development and commercialization of proprietary products that address important therapeutic needs in the field of neuroscience.
  • Home
  • About Us
    • Management Team
    • Board of Directors
  • Investors
    • Press Releases
    • Events & Presentations
    • Proxy Materials
    • SEC Filings
    • Corporate Governance
      • Management Team
      • Board of Directors
      • Committee Composition
    • Stock Information
      • Historic Stock Lookup
    • Analysts
    • Shareholder Tools
      • Shareholder Briefcase
      • Email Alerts
  • Careers
  • Contact
 

For more information, please click here »

News & Events

    Wednesday, May 8, 2013

    Transcept Pharmaceuticals Reports First Quarter 2013 Financial Results

    Wednesday, May 1, 2013

    Transcept Pharmaceuticals to Report First Quarter 2013 Financial Results and Host Conference Call on May 8, 2013

    Wednesday, April 10, 2013

    Thomas J. Dietz, Ph.D., Appointed To The Transcept Pharmaceuticals Board Of Directors

    Thursday, February 28, 2013

    Transcept Pharmaceuticals to Present at Cowen and Company Health Care Conference on March 6
Copyright © 2013  |  
Sitemap  |  Contact Us